Brain Vascular and Neural Function Linked to Balance Across the Adult Lifespan
Recruiting now · Not applicable
Conditions studied: Neurotypical, Cognitively Normal
In brief
This is a single-arm, two-visit, non-randomized, cross sectional study identified as an intervention due to the use of a single bout of aerobic exercise to assess cerebrovascular function under the NIH rules. This study is not masked and its primary purpose is to develop a basic science understanding of the relationship between cerebrovascular health and balance control with aging. This study will involve 102 individuals classified as younger adults, middle-aged adults, and older adults who are neurotypical and cognitively normal. The primary outcome from a clinical trials perspective will be cerebrovascular response to a bout of aerobic exercise (i.e. change in cerebral blood flow with the performance of aerobic exercise on a recumbent stepper exercise machine). Non-interventional outcomes will be EEG measures of cortical activity and biomechanical kinetic and kinematic data recorded during standing balance reactions, as well as biological blood samples for genomic analysis.
Key facts
- Study ID
- NCT06127667
- Run by
- University of Minnesota
- People needed
- 102
- Starts
- 2024-10-15
- Expected to finish
- 2028-07-01
- Last updated by the study team
- 2026-03-27
Who can join
Age: 21 and older, up to 95. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age within the following 3 group age ranges, 21-30yo; middle-aged: 40-55yo; older: 65-95yo adults
- the absence of major orthopedic disability
- cognitively normal (MoCA score ≥ 26/30 in older adult group)
- vision that is 20/40 or better with or without corrective lenses, (5) the ability to consent and communicate with researchers
- English speaking
- ability to stand for 3 minutes and walk 10 meters with or without an assistive device and without the assistance of another person.
You may not qualify if…
- insulin-dependent diabetes
- peripheral neuropathy
- myocardial infarction or symptoms of coronary artery disease within 2 years
- congestive heart failure or class IV heart failure
- any significant sensory impairment affecting balance or cognition; visual, vestibular, or auditory impairments.
Where it is running
- University of Minnesota — Minneapolis, Minnesota, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.